Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles
- 1 November 1997
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 49 (1), 81-87
- https://doi.org/10.1016/s0168-3659(97)00061-8
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Delivery of Loperamide Across the Blood-Brain Barrier with Polysorbate 80-Coated Polybutylcyanoacrylate NanoparticlesPharmaceutical Research, 1997
- Nanoparticles, a drug carrier system to pass the blood-brain barrier, permit central analgesic effects of i.v. dalargin injectionsBrain Research, 1996
- Passage of peptides through the blood-brain barrier with colloidal polymer particles (nanoparticles)Brain Research, 1995
- Uptake of surfactant-coated poly(methyl methacrylate)-nanoparticles by bovine brain microvessel endothelial cell monolayersInternational Journal of Pharmaceutics, 1994
- Colloidal carriers for intravenous drug targeting: Plasma protein adsorption patterns on surface‐modified latex particles evaluated by two‐dimensional polyacrylamide gel electrophoresisElectrophoresis, 1993
- Modification of the body distribution of poly(methyl methacrylate) nanoparticles in rats by coating with surfactantsInternational Journal of Pharmaceutics, 1990
- The organ distribution and circulation time of intravenously injected colloidal carriers sterically stabilized with a blockcopolymer - poloxamine 908Life Sciences, 1987
- The organ uptake of intravenously administered colloidal particles can be altered using a non‐ionic surfactant (Poloxamer 338)FEBS Letters, 1984